Event Details
Presenter Details
Dr. Schaibley is the Administrator for the Center for Applied Genetics and Genomic Medicine (TCAG2M) and the Associate Director of the Genetic Counseling Graduate Program at the University of Arizona. In her role with TCAG2M, she provides administrative and scientific leadership to advance the goals of TCAG2M and the Precision Health Initiative at UAHS. Since 2016, Dr. Schaibley has also worked as part of the leadership team of the Genetic Counseling Graduate Program to develop the new master’s degree program in genetic counseling at UA, which will start in the fall of 2019.
Dr. Schaibley received her PhD in Human Genetics from the University of Michigan, studying patterns of mutation in the human genome using rare variant data obtained from high-throughput sequencing. She has extensive experience in scientific communications, project management, and precision medicine. Prior to joining UA, she worked in a precision medicine start-up company contributing to genetic testing product development, physician and patient-oriented genetic test reports, bioinformatic and data analysis pipelines, and scientific communication strategies.
Continuing Medical Education Credit
Continuing Medical Education (CME) credit is being offered for 2019 - 2020 Genetics and Genomics Grand Rounds series through the University of Arizona College of Medicine - Tucson.
The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
2019 - 2020 Genetics and Genomics Grand Rounds Learning Objectives
- Integrate advances in genetic diagnosis and treatment into the day-to-day practices of research and clinical care.
- Order appropriate diagnostic evaluations for patients with hereditary medical conditions.
All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
Presented By
